Conditions: HIV Infections
Allocation:  | Intervention model: PARALLEL
Enrollment: 630
Healthy volunteers: no

Brief summary:
Demonstrate the safety and efficacy of Tipranavir/Ritonavir versus an active treatment regimen in highly treatment experienced Human Immunodeficiency virus 1(HIV-1) infected patients.

Detailed description:

Arms:
arm 1: None arm 2: None

Interventions: intervention 1: Tipranavir intervention 2: Ritonavir(r) intervention 3: Comparator Protease Inhibitor (CPI)
Intervention descriptions: intervention 1: None intervention 2: None intervention 3: None

Protocol document: